Rare diseases
Investigational molecules
Locations
Back to Slovakia38 clinical trials in Lučenec, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia
SlovakiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone
SlovakiaTitle: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis
SlovakiaStudy of LY3502970 for Adults with Obesity or Overweight and Related Health Issues
SlovakiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
SlovakiaStudy on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia
SlovakiaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atherosclerotic cardiovascular disease. Research includes evaluation of new compounds for reducing major cardiovascular events and improving patient outcomes.
Multiple trials investigating combination therapies and novel approaches to reduce cardiovascular mortality.
Comprehensive research on Type 2 Diabetes and obesity management, exploring innovative treatments and their impact on cardiovascular outcomes. Studies include evaluation of new compounds for weight management and glycemic control.
Advanced clinical trials testing next-generation therapies for metabolic disorders.
Important studies addressing chronic kidney disease and associated conditions. Research focuses on novel combination therapies to slow disease progression and improve outcomes in patients with kidney disorders.
Innovative approaches to treating kidney disease with combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
